TY  - GEN 
AU  - González-Lamuño, D.
AU  - Sánchez Pintos, Paula
AU  - Andrade, F.
AU  - Couce Pico,  María Luz
AU  - Aldámiz-Echevarría, L.
PY  - 2021
SN  - 1750-1172
UR  - http://hdl.handle.net/20.500.11940/18463
AB  - [EN] BACKGROUND: While therapeutic advances have significantly improved the prognosis of patients with hereditary tyrosinemia type 1 (HT1), adherence to dietary and pharmacological treatments is essential for an optimal clinical outcome. Poor...
LA  - en
TI  - Treatment adherence in tyrosinemia type 1 patients
DO  - 10.1186/s13023-021-01879-1
KW  - CHUS
KW  - IDIS
VL  - 16
ER  -